Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer

被引：0
|
作者：
Hajime Abe
Tsuyoshi Mori
Yuki Kawai
Hirotomi Cho
Yoshihiro Kubota
Tomoko Umeda
Yoshimasa Kurumi
Tohru Tani
机构：
[1] Shiga University of Medical Science Hospital,Division of Breast and General Surgery
[2] Shiga University of Medical Science,Department of Comprehensive Surgery
[3] Shiga University of Medical Science,Department of Surgery
来源：
International Journal of Clinical Oncology | 2013年 / 18卷
关键词：
Adjuvant chemotherapy; Docetaxel; Early breast cancer; Feasibility; FEC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 491
页数：4
相关论文
共 50 条
  • [1] Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer
    Abe, Hajime
    Mori, Tsuyoshi
    Kawai, Yuki
    Cho, Hirotomi
    Kubota, Yoshihiro
    Umeda, Tomoko
    Kurumi, Yoshimasa
    Tani, Tohru
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 487 - 491
  • [2] Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin, and cyclophosphamide as adjuvant chemotherapy for early-stage breast cancer
    Abe, H.
    Umeda, T.
    Kawai, Y.
    Tanaka, M.
    Shimizu, T.
    Chou, H.
    Kubota, Y.
    Mekata, E.
    Kurumi, Y.
    Tani, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel plus epirubicin and cyclophosphamide
    Andersen, Kenneth Geving
    Jensen, Maj-Britt
    Kehlet, Henrik
    Gartner, Rune
    Eckhoff, Lise
    Kroman, Niels
    [J]. ACTA ONCOLOGICA, 2012, 51 (08) : 1036 - 1044
  • [4] Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
    Poole, Christopher J.
    Earl, Helena M.
    Hiller, Louise
    Dunn, Janet A.
    Bathers, Sarah
    Grieve, Robert J.
    Spooner, David A.
    Agrawal, Rajiv K.
    Fernando, Indrajit N.
    Brunt, A. Murray
    O'Reilly, Susan M.
    Crawford, S. Michael
    Rea, Daniel W.
    Simmonds, Peter
    Mansi, Janine L.
    Stanley, Andrew
    Harvey, Peter
    McAdam, Karen
    Foster, Liz
    Leonard, Robert C. F.
    Twelves, Christopher J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (18): : 1851 - 1862
  • [5] Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
    Zhang, Minmin
    Wei, Wei
    Liu, Jianlun
    Yang, Huawei
    Jiang, Yi
    Tang, Wei
    Li, Qiuyun
    Liao, Xiaoming
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 3443 - 3450
  • [6] Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer
    Iwata, Hiroji
    Sato, Nobuaki
    Masuda, Norikazu
    Nakamura, Seigo
    Yamamoto, Naohito
    Kuroi, Katsumasa
    Kurosumi, Masafumi
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Ohashi, Yasuo
    Toi, Masakazu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 867 - 875
  • [7] Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients
    Sanna, G.
    Pestrin, M.
    Zafarana, E.
    Biagioni, C.
    Cavaciocchi, D.
    Turner, N.
    Di Leo, A.
    Biganzoli, L.
    [J]. BREAST, 2013, 22 (05): : 926 - 932
  • [8] Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: Is it cost-effective?
    Norum, J
    Holtmon, M
    [J]. ACTA ONCOLOGICA, 2005, 44 (07) : 735 - 741
  • [9] Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer.
    Santos, F. N.
    Cruz, M. R.
    Cezana, L.
    Costa, L. A.
    de Azevedo, C. A.
    De Barros, M. J.
    Silva, E.
    Cozario, L. L.
    Alencar, A. M., Jr.
    Fanelli, M. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Feasibility Study of Docetaxel with Cyclophosphamide as Adjuvant Chemotherapy for Japanese Breast Cancer Patients
    Takabatake, Daisuke
    Taira, Naruto
    Hara, Fumikata
    Sien, Tadahiko
    Kiyoto, Sachiko
    Takashima, Seiki
    Aogi, Kenjiro
    Ohsumi, Shozo
    Doihara, Hiroyoshi
    Takashima, Shigemitu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (08) : 478 - 483
12345